✦ LIBER ✦

1–39 Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

✍ Scribed by Carey, L.A.

Book ID: 123455063
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 69 KB
Volume: 16
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(05)80060-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5176 POSTER Gene Expression Profiles Pre

5176 POSTER Gene Expression Profiles Predict Pathological Complete Response to Standard Neoadjuvant Fluorouracil, Doxorubicin, and Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Early Breast Cancer

✍ Tamura, K.; Koizumi, F.; Shimizu, C.; Hojo, T.; Akashi-Tanaka, S.; Kinoshita, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Neoadjuvant chemotherapy paclitaxel + do

Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response

✍ V.F. Semiglazov; A.A. Bojok; A.S. Arsumanov; O.A. Ivanova; V.G. Ivanov; V.V. Sem 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Gene expression and pathologic response

Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer

✍ Kolacinska, Agnieszka; Fendler, Wojciech; Szemraj, Janusz; Szymanska, Bozena; Bo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 272 KB

GSTP1 expression predicts poor pathologi

GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer

✍ Tomohiro Miyake; Takahiro Nakayama; Yasuto Naoi; Noriaki Yamamoto; Yoko Otani; S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

CD24 Polymorphisms Cannot Predict Pathol

CD24 Polymorphisms Cannot Predict Pathologic Complete Response to Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy in Breast Cancer

✍ Zhou, Xin 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 802 KB

Correlation between HER-2 expression and

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

✍ Fan Zhang; Ying Yang; Terry Smith; Shu-Wan Kau; Judy M. McConathy; Francisco J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine whether HER‐2 overexpression is associated with improved response to neoadjuvant chemotherapy with 5‐fluorouracil, doxorubicin, cyclophosphamide (FAC) in patients with breast carcinoma. ## METHODS Ninety‐seven patients with S